Sign in
4

Changes in Ownership

Adicet Bio, Inc. Filed Acc 0001209191-23-046103

Options or other derivatives

  • President & CEO acquired 2,250,468 shares (grant or award)
  • President & CEO returned 2,250,468 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Schor Chen · President & CEO

Table II: Derivative

12 lines
Date Transaction Shares Owned after D/I
2023-08-14 Returned to the company : show line 1 in the form Stock Option (Right to Buy) −36,857 0 D
2023-08-14 Grant or award : show line 2 in the form Stock Option (Right to Buy) +36,857 36,857 D
2023-08-14 Returned to the company : show line 3 in the form Stock Option (Right to Buy) −872,111 0 D
2023-08-14 Grant or award : show line 4 in the form Stock Option (Right to Buy) +872,111 872,111 D
2023-08-14 Returned to the company : show line 5 in the form Stock Option (Right to Buy) −240,000 0 D
2023-08-14 Grant or award : show line 6 in the form Stock Option (Right to Buy) +240,000 240,000 D
2023-08-14 Returned to the company : show line 7 in the form Stock Option (Right to Buy) −421,600 0 D
2023-08-14 Grant or award : show line 8 in the form Stock Option (Right to Buy) +421,600 421,600 D
Loading xslF345X05/doc4.xml…